Latest Article on Diabetes
![Doctors Appointment This pictures shows a healthcare professional during her work.](/sites/default/files/2023-11/Exandra_Teasercard_Webseite.png)
Digital solution for individualized diabetes care
![Family portrait diabetes patient](/sites/default/files/2022-06/jurjen_dabetes_patient_family_02_0.jpg)
Living a long and healthy life
![Blood Cell](/sites/default/files/2021-11/211126_The_Adventures_of_Reggie_the%20Red_Blood_Cell_teaser_card_1440%20x%20810_0.jpg)
The Adventures of Reggie the Red Blood Cell
![New positive data in Phase III type 2 diabetes trial](/sites/default/files/2022-12/shutterstock_1021932094.jpg)
Phase III trial demonstrated Jardiance is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes
![Medical worker showing a heart](/sites/default/files/2022-06/EMPRISE_website_card_image_16_9.jpg)
Jardiance® (empagliflozin) decreased relative risk of hospitalization for heart failure by 50% versus DPP-4 inhibitors and by 30% versus GLP-1 receptor agonists in adults with type 2 diabetes in real-world evidence study
Links
Heart Talks
Heart Failure Matters
Downloads
Diabetic Retinopathy
Harold and Dorothy Patient Discussion Factsheet
Type 2 Diabetes
1 Diabetes Atlas 8th edition 2017, International Diabetes Federation. http://www.diabetesatlas.org (accessed Jan 2019)